Tīmeklis2024. gada 10. janv. · EZH-1301 (Solid Tumor) and EZH-1501 (Hematological) Basket Studies: The Company recently opened sites for these two basket studies, which … TīmeklisEZH-1301 (Solid Tumor) and EZH-1501 (Hematological) Basket Studies: Epizyme recently opened sites for these two basket studies, which sites are actively screening patients for enrollment in each of the studies. Epizyme plans to provide updates as the studies reach key enrollment milestones, as well as preliminary data in 2024. ...
Epizyme Reports Fourth Quarter and Full Year 2024 ... - Business …
Tīmeklis2024. gada 10. maijs · Global enrollment open and actively screening in the randomized Phase 3 portion of SYMPHONY-1 (EZH-302): ... We continue to screen patients in … Tīmeklis2024. gada 10. janv. · EZH-1301 (Solid Tumor) and EZH-1501 (Hematological) Basket Studies: During the fourth quarter of 2024, Epizyme initiated two basket studies – EZH-1301 and EZH-1501, to evaluate tazemetostat combinations in patients with solid tumors and hematological malignancies, respectively. sushi shop twitter
Epizyme (EPZM) Q4 Loss Wider Than Expected, Revenues Lag
Tīmeklis2024. gada 10. maijs · We continue to screen patients in ARIA (EZH-1501), the Phase 1b/2 tazemetostat hematological basket study, and SET-101, the Phase 1/1b study of EZM0414. Epizyme plans to provide updates on these programs in the second half of 2024. First Quarter 2024 Financial Results. Tīmeklis2024. gada 11. maijs · EPZM initiated a phase Ib/II basket study, ARIA (EZH-1501), during fourth-quarter 2024 to evaluate the safety and efficacy of tazemetostat across multiple new types of hematological malignancies. sixty vw bug